Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) Shares Outstanding (Weighted Average): 2023-2024

Historic Shares Outstanding (Weighted Average) for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $14.5 million.

  • Inhibrx Biosciences' Shares Outstanding (Weighted Average) rose 0.07% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 0.07%. This contributed to the annual value of $14.5 million for FY2024, which is 8.18% up from last year.
  • Inhibrx Biosciences' Shares Outstanding (Weighted Average) amounted to $14.5 million in FY2024, which was up 8.18% from $13.4 million recorded in FY2023.
  • Inhibrx Biosciences' 5-year Shares Outstanding (Weighted Average) high stood at $14.5 million for FY2024, and its period low was $13.4 million during FY2023.
  • Its 2-year average for Shares Outstanding (Weighted Average) is $13.9 million, with a median of $13.9 million in 2023.
  • Data for Inhibrx Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY grew of 8.18% (in 2024) over the last 5 years.
  • Inhibrx Biosciences' Shares Outstanding (Weighted Average) (Yearly) stood at $13.4 million in 2023, then climbed by 8.18% to $14.5 million in 2024.